Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Shares and oil slide as sanctions, virus fears strike

Tue, 23rd Mar 2021 11:21

(Recasts)

* U.S., Europe sanctions against China hit shares

* Powell to testify on U.S. recovery

* Oil slides 4% amid demand fears

* European shares slip

* Global currencies vs. dollar https://tmsnrt.rs/2PmYOcE

By Lawrence White and Alun John

LONDON/HONG KONG, March 23 (Reuters) - Shares slipped from a
one-year peak, sovereign bond yields fell, and oil prices
slumped as a wave of coronavirus infections, a fresh lockdown in
Germany and U.S. and European sanctions over China combined to
curb risk appetite worldwide.

The STOXX index of 600 European shares fell 0.4%,
while the benchmark 10-year German government bond yield dropped
4 basis points to -0.351% and gold inched up as
investors sought safer assets.

U.S. markets appeared set to inherit the negative mood with
S&P 500 futures down 0.4% ahead of Congressional
testimony by Fed Chair Jerome Powell and Treasury Secretary
Janet Yellen later in the day.

In remarks prepared for delivery to a congressional hearing
on Tuesday morning, the Fed chief Powell said the U.S. economic
recovery had progressed "more quickly than generally expected".

"The FOMC last week laid out pretty clearly what the Fed's
view is with regard to rates... the next thing that markets will
focus on is maybe getting some details from Yellen with regard
to further infrastructure investment," said Alex Wolf head of
investment strategy for Asia at J.P. Morgan Private Bank,
referring to a statement from the Federal Open Market Committee.

MIXED MOOD

A mixed bag of new Western sanctions on China, coronavirus
concerns and Turkish tumult after President Tayyip Erdogan's
shock sacking of the central bank chief at the weekend left
investors awaiting a firmer signal.

The Turkish lira appeared to find a floor after Monday's
historic 7.5% slump, rising as much as 1% in volatile trading to
7.7192 against the dollar.

In Asia, MSCI's broadest index of Asia-Pacific shares
outside Japan dropped 0.66%, hurt by a 0.95%
fall in Chinese blue chips as a fresh wave of U.S. and
European sanctions related to human rights abuses in Xinjiang
hit.

The sanctions on China prompted an immediate riposte from
Beijing against the EU that appeared broader, including European
lawmakers, diplomats, institutes and families.

Adding to market jitters were further worries over the
efficacy of the AstraZeneca Plc vaccine developed with
Oxford University after a U.S. health agency said the drugmaker
may have included outdated information in its data.

SUMMER CANCELLED?

Oil prices fell 4%, hit by concerns that new pandemic curbs
and slow vaccine rollouts in Europe will hold back a recovery in
demand along with fresh travel restrictions.

Brent crude futures dropped by $2.59, or 4%, to
$62.03 a barrel by 1108 GMT. U.S. West Texas Intermediate (WTI)
crude futures fell by $2.43, or 3.95%, to $59.11 a
barrel.

"Global travel is still looking like it could be a while
away," said Matt Stanley, a fuel broker at Star Fuels in Dubai,
adding that a second-half recovery in oil demand looked doubtful
as lockdowns remain the order of the day.

Benchmark 10-year U.S. Treasury notes last
yielded 1.6505%, down from 1.732% late on Friday.

The dollar gained slightly against a basket of six major
currencies last trading at 92.019, having slipped 0.32%
on Monday, while making advances against the kiwi, Aussie and
sterling.

Spot gold rose slightly to $1,740 per ounce by 1100
GMT, buoyed by easing U.S. Treasury yields.

The New Zealand dollar hit a three-month low after
the government introduced taxes to curb housing speculation, a
move investors reckoned could allow the central bank to hold
interest rates lower for longer with less risk of a property
bubble.

(Reporting by Alun John in Hong Kong, Chris Prentice in
Washington, Lawrence White in London; Additional reporting by
Luoyan Liu in Shanghai
Editing by Sam Holmes, Gerry Doyle, Susan Fenton, Peter Graff)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.